Suppr超能文献

在原发性胶质母细胞瘤患者中,miR-21、miR-34a、miR-125b、miR-181d和miR-648的水平与MGMT和TP53的表达呈负相关。

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients.

作者信息

Jesionek-Kupnicka Dorota, Braun Marcin, Trąbska-Kluch Berenika, Czech Joanna, Szybka Małgorzata, Szymańska Bożena, Kulczycka-Wojdala Dominika, Bieńkowski Michał, Kordek Radzisław, Zawlik Izabela

机构信息

Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland.

Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.

出版信息

Arch Med Sci. 2019 Mar;15(2):504-512. doi: 10.5114/aoms.2017.69374. Epub 2017 Jul 31.

Abstract

INTRODUCTION

and alterations play a crucial role in glioblastoma (GB) pathogenesis. and function is affected by several pathologic mechanisms, such as point mutations or promoter methylation, which are well characterized. Expression of both genes can be regulated by other mechanisms as well, e.g., microRNAs (miRNAs). Moreover, cross-talk among various pathologic processes may occur, further affecting and functionality.

MATERIAL AND METHODS

In 49 GB patients, we analyzed the possible associations between and its miRNA regulators , , and , as well as and its miRNA regulators and . We evaluated the possible influence of mutational and methylation status on the pre-identified associations.

RESULTS

In patients with immunohistochemistry-detected overexpression, expression levels of and were negatively correlated ( = -0.56, = 0.0195), and in patients with mutations, expression levels of and were negatively correlated ( = -0.67, = 0.0330). In patients with methylation, expression levels of were negatively correlated with and expression levels ( = -0.61, = 0.0269 and = -0.34, = 0.0727, respectively).

CONCLUSIONS

Our findings demonstrate that selected miRNAs are significantly correlated with and levels, but the extent of this correlation differs regarding the and mutational and promoter methylation status.

摘要

引言

[基因名称1]和[基因名称2]的改变在胶质母细胞瘤(GB)发病机制中起关键作用。[基因名称1]和[基因名称2]的功能受多种病理机制影响,如点突变或启动子甲基化,这些已得到充分表征。这两个基因的表达也可受其他机制调控,例如微小RNA(miRNA)。此外,各种病理过程之间可能发生相互作用,进一步影响[基因名称1]和[基因名称2]的功能。

材料与方法

在49例GB患者中,我们分析了[基因名称1]与其miRNA调节因子[miRNA名称1]、[miRNA名称2]和[miRNA名称3]之间以及[基因名称2]与其miRNA调节因子[miRNA名称4]和[miRNA名称5]之间的可能关联。我们评估了突变和甲基化状态对预先确定的关联的可能影响。

结果

在免疫组化检测到[基因名称1]过表达的患者中,[基因名称2]和[miRNA名称6]的表达水平呈负相关(r = -0.56,P = 0.0195),在有[基因名称1]突变的患者中,[基因名称2]和[miRNA名称7]的表达水平呈负相关(r = -0.67,P = 0.0330)。在有[基因名称2]甲基化的患者中,[基因名称2]的表达水平与[基因名称1]和[miRNA名称8]的表达水平呈负相关(分别为r = -0.61,P = 0.0269和r = -0.34,P = 0.0727)。

结论

我们的研究结果表明,所选miRNA与[基因名称1]和[基因名称2]水平显著相关,但这种相关性的程度因[基因名称1]和[基因名称2]的突变及启动子甲基化状态而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c568/6425218/a57d54c59493/AMS-15-30454-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验